Trade Novavax NVAX

Novavax live chart

instrument_fundamentals

Weekly Search
Weekly
Daily
date Close change Change (%) instr__open High Low

Novavax news

2021 May 11, 13:20

US pre-market: selling unabated

2021 May 06, 08:27

Stocks rally as Fed speakers get back on script, earnings support + Bank of England set to raise forecasts

2021 Feb 28, 07:36

Week Ahead: RBA speaks, US NFPs released & OPEC clash

2020 May 26, 08:04

Leg up: stocks make new ground, travel stocks soar

Latest news

Show more
Ava Grace 2025 Jul 17, 13:20

US Consumer Spending Defies Tariff Impact: Resilience or Price Inflation?

Ava Grace 2025 Jul 17, 10:21

Gold Price Forecast 2025-2026: A Comprehensive Analysis by the World Gold Council

Sophia Claire 2025 Jul 17, 10:20

EU Prepares Retaliatory Measures Against US Amid Trade Dispute

Sophia Claire 2025 Jul 17, 07:20

Analyzing Trump's Tariff Threats: Are European Markets Underestimating the Risk?

Liam James 2025 Jul 17, 06:20

Iran's Khamenei: Ready for Stronger Response to Potential Attacks

Noah Lee 2025 Jul 17, 05:20

US House Advances Crypto Bill After Republican Standoff

Ava Grace 2025 Jul 17, 01:20

US Bankers Defend Federal Reserve Independence Amid Political Pressure

Noah Lee 2025 Jul 17, 01:20

US Economy in Uncertainty: Tariffs and Labor Shortages Worry Businesses

Info

Spread

0.05

Spread (%)

0.7246 %

Leverage

1:10

Overnight Interest Buy

-0.0597 %

Overnight Interest Sell

-0.0292 %

Currency

USD

Trading Hours

Market open

Thursday

13:31 - 19:59

Monday

13:31-19:59

Tuesday

13:31-19:59

Wednesday

13:31-19:59

Friday

13:31-19:59

instr__analysis_statistics

instr__open

---

instr__close

---

instr__52week_range

--- – ---

instr__market_cap

1114353664

instr__shares_outstand

161970000

instr__earnings_date

2019-05-10

instr__dividend_date

2019-05-10

instr__ex_dividend_date

instr__forward_annual_dividend_rate

0

instr__forward_annual_dividend_yield

0

instr__eps

2.75

instrument_learn_more

Novavax Novavax Inc
Novavax, Inc., a biotechnology company, engages in the discovering, developing, and commercializing vaccines to protect against serious infectious diseases in the United States, Europe, and internationally. The company offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It also developing R21/Matrix-M adjuvant malaria vaccine. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.
Markets.com Bonus Trading

related_instruments

view_all_instruments

latest_education_articles

Show more
Trustpilot